These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24024221)

  • 1. Selective serotonin re-uptake inhibitors--a review of the side effects in adolescents.
    Gordon M; Melvin G
    Aust Fam Physician; 2013 Sep; 42(9):620-3. PubMed ID: 24024221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review.
    Sharp SC; Hellings JA
    Clin Drug Investig; 2006; 26(5):247-55. PubMed ID: 17163258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases.
    Dubrall D; Fekete S; Leitzen S; Paschke LM; Romanos M; Schmid M; Gerlach M; Sachs B
    BMC Pharmacol Toxicol; 2023 Mar; 24(1):22. PubMed ID: 37004083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACNP Task Force report on SSRIs and suicidal behavior in youth.
    Mann JJ; Emslie G; Baldessarini RJ; Beardslee W; Fawcett JA; Goodwin FK; Leon AC; Meltzer HY; Ryan ND; Shaffer D; Wagner KD
    Neuropsychopharmacology; 2006 Mar; 31(3):473-92. PubMed ID: 16319919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SSRIs and risk of suicide attempts in young people - A Danish observational register-based historical cohort study, using propensity score.
    Christiansen E; Agerbo E; Bilenberg N; Stenager E
    Nord J Psychiatry; 2016; 70(3):167-75. PubMed ID: 26251067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants and suicidal behaviour in the Psychiatric Emergency Clinic - preliminary report.
    Pregelj P; Ziherl S
    Psychiatr Danub; 2008 Jun; 20(2):224-6. PubMed ID: 18587294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of major depression in adolescents: weighing the evidence of risk and benefit in light of black box warnings.
    Lovrin M
    J Child Adolesc Psychiatr Nurs; 2009 May; 22(2):63-8. PubMed ID: 19490276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.
    Weller EB; Tucker S; Weller RA
    Curr Psychiatry Rep; 2005 Apr; 7(2):87-90. PubMed ID: 15802083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antidepressants and suicide in adolescents].
    Silva M; Sampaio D
    Acta Med Port; 2011; 24(4):603-12. PubMed ID: 22521018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
    Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing common Side effects of SSRIs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Feb; 45(2):15-8. PubMed ID: 17334198
    [No Abstract]   [Full Text] [Related]  

  • 20. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.